• EryDel Announces Top-line Results from Phase 3 ATTeST Trial Demonstrating Significant Clinical Benefit of EryDex in Ataxia Telangiectasia

  • ATTeST trial latest news further to CoVID19 emergency


    The Corona virus pandemic has deeply affected our lives and EryDel, as sponsor of the ATTeST study, wants to provide patients and families involved in the study with the latest news about ATTeST, given the fast moving nature of events.

powered by

EryDel Logo

Copyright © 2016 ATTeST. All rights reserved.

Privacy policy – Cookie policy

EryDel is fully committed to ensuring patient privacy. To better protect your privacy, we set out here our corporate Privacy Policy so that you will understand our commitment to you and to your privacy.

Our policies adhere to data-protection legislations applicable clinical research activities, including the clinical study sponsored by EryDel. These policies adhere to the privacy principles agreed to by the US Department of Commerce and the European Economic Area and Switzerland. The information provided below outlines specific policies and commitments related to the management of this website.

Contacting a Study Site

In case you chose to contact a Study Site, the information will not be accessible to EryDel and is not stored or retained by EryDel in any manner. EryDel will be notified that an information request was submitted to the study site, but will not have access to the contents of the submission, including your name and contact information. The study site will receive the information you provide as an email. As such, the email will be retained on their servers indefinitely and will be subject to the privacy and security policies of that medical institution.


If you elect to send an email to info@erydel.com, your personal information will only be shared with EryDel. Your information will NOT be shared with any other party. EryDel understands the importance of protecting your information and will use your information for the sole purpose of responding to your inquiry. Once your email has been responded to, the email will be deleted. However, your email will be stored on EryDel servers indefinitely since these data cannot be deleted. The email box will be reviewed once per week and you can expect a response within 14 days or less.

Log Files and Aggregate Information

We may track the total number of visitors to our website, the number of visitors to each page of our website, IP addresses, and we may analyze these data for trends and statistics in the aggregate, but such information will be in aggregate form only and it will not contain personally identifiable data. Such aggregate information is not linked to any personally identifiable information specific to any individual person. We may use such aggregate information to analyze trends, administer the website, track browser movement, and gather broad demographic information for aggregate use.